Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus (CN): Results of a Study in Ten Adult Patients (Phase 1)

Go back to Resources

Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus (CN): Results of a Study in Ten Adult Patients (Phase 1)

Authors:

Location:

Go back to Resources

Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus

Go back to Resources

Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus

Authors:

Location:

Go back to Resources

Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults

Go back to Resources

Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation

Go back to Resources

Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Descriptions of benefits and risks in consent forms for Phase 1 oncology trials

Go back to Resources

Descriptions of benefits and risks in consent forms for Phase 1 oncology trials

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Conjunctiva T-Cell subpopulations in Jorgen’s and non-Jorgen’s patients with dry eye

Go back to Resources

Conjunctiva T-Cell subpopulations in Jorgen’s and non-Jorgen’s patients with dry eye

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Comparative study of the safety, efficacy, and practice patterns of Monoclonal antibodies (MAbs) in pediatric renal transplantation (PRT)

Go back to Resources

Comparative study of the safety, efficacy, and practice patterns of Monoclonal antibodies (MAbs) in pediatric renal transplantation (PRT)

Authors:

Location:

Go back to Resources

Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV+ patients

Go back to Resources

Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV+ patients

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials

Go back to Resources

Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials

Authors:

Location:

Go back to Resources

Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study

Go back to Resources

Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • Current page 135
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions